These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31297182)

  • 1. Recent advances in therapies for onychomycosis and its management.
    Gupta AK; Stec N
    F1000Res; 2019; 8():. PubMed ID: 31297182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for the treatment of onychomycosis.
    Gupta AK; Stec N
    Expert Opin Emerg Drugs; 2019 Dec; 24(4):213-220. PubMed ID: 31652088
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Lasers for the Management of Dermatophyte Toenail Onychomycosis.
    Gupta AK; Venkataraman M; Quinlan EM
    J Am Podiatr Med Assoc; 2022 Mar; 112(1):. PubMed ID: 34233353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of toenail onychomycosis.
    Tom CM; Kane MP
    Am J Health Syst Pharm; 1999 May; 56(9):865-71. PubMed ID: 10344609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antifungal therapies for the treatment of onychomycosis.
    Kumar S; Kimball AB
    Expert Opin Investig Drugs; 2009 Jun; 18(6):727-34. PubMed ID: 19426118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective is efinaconazole in the management of onychomycosis?
    Gupta AK; Cernea M
    Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Drug Use for Onychomycosis.
    Thomas J; Peterson GM; Christenson JK; Kosari S; Baby KE
    Am J Ther; 2019; 26(3):e388-e396. PubMed ID: 31082864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapies for the treatment of ungual onychomycosis.
    Kushwaha A; Murthy RN; Murthy SN; Elkeeb R; Hui X; Maibach HI
    Drug Dev Ind Pharm; 2015; 41(10):1575-81. PubMed ID: 25997365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
    Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.
    Stasko N; McHale K; Hollenbach SJ; Martin M; Doxey R
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.
    Del Rosso JQ
    J Am Osteopath Assoc; 1997 Jun; 97(6):339-46. PubMed ID: 9232944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and surgical treatment of onychomycosis.
    Cohen PR; Scher RK
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S74-7. PubMed ID: 8077513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and physical strategies in onychomycosis topical treatment: A review.
    Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
    Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tavaborole - a treatment for onychomycosis of the toenails.
    Gupta AK; Versteeg SG
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimycotic therapy of Tinea unguium and other onychomycoses].
    Stock I
    Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.
    Gupta AK; Versteeg SG; Shear NH; Piguet V; Tosti A; Piraccini BM
    Am J Clin Dermatol; 2019 Feb; 20(1):123-133. PubMed ID: 30456537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel investigational therapies for onychomycosis: an update.
    Gupta AK; Studholme C
    Expert Opin Investig Drugs; 2016; 25(3):297-305. PubMed ID: 26765142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational drugs for onychomycosis.
    Gupta AK; Simpson FC
    Expert Opin Investig Drugs; 2014 Jan; 23(1):97-106. PubMed ID: 24070182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.